In the fast-moving field of gynecological surgery, precision and safety remain the ultimate goals. TRIANGEL is proud to highlight the clinical impact of advanced diode laser technology operating at 980 nm and 1470 nm wavelengths. These systems, widely recognized as Dual-Wavelength Laser Systems , are rapidly becoming the standard of care for office-based, minimally invasive procedures.
Why Two Wavelengths?
The 980 nm wavelength is highly absorbed by hemoglobin, making it exceptionally effective for Hemostasis (bleeding control). In contrast, the 1470 nm wavelength has a high absorption coefficient in water, enabling rapid Vaporization and precise cutting of soft tissue. When combined in a Dual-Wavelength Laser Systems, these two wavelengths allow gynecologists to switch seamlessly between coagulation and ablation, significantly reducing surgical time, blood loss, and thermal damage to surrounding healthy tissue.
Clinical Evidence: Improving Vaginal Health
Recent clinical studies have validated the use of dual-wavelength Endolaser for treating Vulvovaginal Atrophy (VVA) , a common condition affecting postmenopausal women. In a prospective trial published in the Journal of Clinical Medicine, patients treated with a 980 nm + 1470 nm diode laser showed substantial improvement in the Vaginal Health Index (VHI) —a composite score measuring elasticity, fluid volume, pH, and epithelial integrity. Specifically, VHI scores increased from an average of 12.2 to 20.1 at 12-week follow-up. Furthermore, dyspareunia (painful intercourse) scores dropped significantly, with over 85% of patients reporting no or mild pain. No serious adverse events were noted, and 92% of patients would recommend the procedure to others.
Expanding Applications in Gynecology
Beyond VVA, TRIANGEL Endolaser technology is being successfully applied to:
Office hysteroscopic metroplasty for septate uterus, with studies showing increased endometrial volume and improved reproductive outcomes.
Intrauterine lesion removal including endometrial polyps and small fibroids, often without cervical dilation or general anesthesia.
Myolysis of uterine fibroids, achieving up to 46% volume reduction in ex vivo models — a promising fertility-sparing alternative to hysterectomy.
The TRIANGEL Advantage
TRIANGEL is committed to bringing state-of-the-art laser solutions to gynecological practices worldwide. Our dual-wavelength Endolaser systems are specifically engineered for reliable, repeatable hemostasis and vaporization, enabling true Outpatient procedures. With shorter learning curves, reduced bleeding, and faster patient recovery, TRIANGEL’s Endolaser technology empowers clinicians to deliver better outcomes while lowering healthcare costs.
Conclusion
The combination of 980 nm and 1470 nm in a single Endolaser platform marks a major leap forward for gynecological surgery. By enhancing the VHI, ensuring precise Hemostasis, and enabling pain-free Outpatient treatments, TRIANGEL Endolaser is reshaping what patients and surgeons can expect from modern gynecologic care.
Post time: Apr-24-2026